Proportions of Kaposi Sarcoma, Selected Non-Hodgkin Lymphomas, and Cervical Cancer in the United States Occurring in Persons with AIDS, 1980-2007

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2011 Apr 14

PMID 21486978

Citations 83

Authors

Meredith S Shiels

Ruth M Pfeiffer

H Irene Hall

Jianmin Li

James J Goedert

Lindsay M Morton

Patricia Hartge

Eric A Engels

Affiliations

Soon will be listed here.

Abstract

Context: Given the higher risk of AIDS-defining malignancies that include Kaposi sarcoma (KS), certain non-Hodgkin lymphomas (NHLs), and cervical cancer in persons with human immunodeficiency virus (HIV) infection, the HIV epidemic has likely contributed to the overall numbers of these cancers in the United States.

Objective: To quantify the proportions of KS, AIDS-defining NHLs, and cervical cancer in the United States that occurred among persons with AIDS from 1980 to 2007.

Design, Setting, And Participants: The HIV/AIDS Cancer Match Study (1980-2007) linked data from 16 US HIV/AIDS and cancer registries to identify cases with and without AIDS for KS, AIDS-defining NHLs (ie, diffuse large B-cell lymphoma [DLBCL], Burkitt lymphoma [BL], and central nervous system [CNS] lymphoma), and cervical cancer. Using linked data, we derived cancer rates for persons with and without AIDS. To estimate national counts, the rates were applied to national AIDS surveillance and US Census data.

Main Outcome Measure: Proportion of AIDS-defining malignancies in the United States occurring in persons with AIDS.

Results: In the United States, an estimated 81.6% (95% confidence interval [CI], 81.2%-81.9%) of 83,252 KS cases, 6.0% (95% CI, 5.8%-6.1%) of 351,618 DLBCL cases, 19.9% (95% CI, 18.1%-21.7%) of 17,307 BL cases, 27.1% (95% CI, 26.1%-28.1%) of 27,265 CNS lymphoma cases, and 0.42% (95% CI, 0.37%-0.47%) of 375,452 cervical cancer cases occurred among persons with AIDS during 1980-2007. The proportion of KS and AIDS-defining NHLs in persons with AIDS peaked in the early 1990s (1990-1995: KS, 90.5% [95% CI, 90.2%-90.8%]; DLBCL, 10.2% [95% CI, 9.9%-10.5%]; BL, 27.8% [95% CI, 25.0%-30.5%]; and CNS lymphoma, 48.3% [95% CI, 46.7%-49.8%]; all P < .001 [compared with 1980-1989]) and then declined (2001-2007: KS, 70.5% [95% CI, 68.1%-73.0%]; DLBCL, 4.7% [95% CI, 4.3%-5.2%]; BL, 21.5% [95% CI, 17.7%-25.4%]; and CNS lymphoma, 12.9% [95% CI, 10.5%-15.3%]; all P < .001 [compared with 1990-1995]). The proportion of cervical cancers in persons with AIDS increased over time (1980-1989: 0.11% [95% CI, 0.09%-0.13%]; 2001-2007: 0.71% [95% CI, 0.51%-0.91%]; P < .001).

Conclusions: In the United States, the estimated proportions of AIDS-defining malignancies that occurred among persons with AIDS were substantial, particularly for KS and some NHLs. Except for cervical cancer, the proportions of AIDS-defining malignancies occurring among persons with AIDS peaked in the mid-1990s and then declined.

Citing Articles

Burkitt's Lymphoma of the Uterine Cervix in a Woman with Advanced HIV Disease: A Case Report on Challenges with Its Management in a Low Resource Setting.

de Miranda L, Uzabakiriho B, Louw M, Ngene N Int Med Case Rep J. 2025; 18:281-287.

PMID: 40052087 PMC: 11883410. DOI: 10.2147/IMCRJ.S500905.

Double-Hit Diffuse Large B-Cell Lymphoma in AIDS.

S S, Moorthy S Cureus. 2024; 16(11):e73190.

PMID: 39651017 PMC: 11624958. DOI: 10.7759/cureus.73190.

A case report of surgery-radiotherapy-chemotherapy cured primary diffuse large B-cell lymphoma of the central nervous system associated with HIV infection.

Zhang Q, Lai J, Ai S, Song S, Jiang J, Xie Z Diagn Pathol. 2024; 19(1):153.

PMID: 39593138 PMC: 11590278. DOI: 10.1186/s13000-024-01562-6.

HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.

Lurain K, Ramaswami R, Krug L, Whitby D, Ziegelbauer J, Wang H Clin Microbiol Rev. 2024; 37(3):e0002223.

PMID: 38899877 PMC: 11391709. DOI: 10.1128/cmr.00022-23.

Factors Associated With Precancerous Cervical Lesions in Human Immunodeficiency Virus-Infected Women: A Cross-Sectional Survey in Togo.

Darre T, Djiwa T, Ladekpo K, MBortche B, Douaguibe B, Aboubakari A Clin Med Insights Oncol. 2024; 18:11795549241234620.

PMID: 38510316 PMC: 10953098. DOI: 10.1177/11795549241234620.

References

Bedimo R, Chen R, Accortt N, Raper J, Linn C, Allison J . Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004; 39(9):1380-4. DOI: 10.1086/424883. View

McDavid Harrison K, Kajese T, Hall H, Song R . Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008; 123(5):618-27. PMC: 2496935. DOI: 10.1177/003335490812300512. View

Chiao E, Dezube B, Krown S, Wachsman W, Brock M, Giordano T . Time for oncologists to opt in for routine opt-out HIV testing?. JAMA. 2010; 304(3):334-9. PMC: 3160789. DOI: 10.1001/jama.2010.752. View

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

Bellan C, De Falco G, Lazzi S, Leoncini L . Pathologic aspects of AIDS malignancies. Oncogene. 2003; 22(42):6639-45. DOI: 10.1038/sj.onc.1206815. View

Bashir R, McManus B, Cunningham C, Weisenburger D, Hochberg F . Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients. J Neurooncol. 1994; 20(1):47-53. DOI: 10.1007/BF01057960. View

Goedert J, Cote T, Virgo P, Scoppa S, Kingma D, Gail M . Spectrum of AIDS-associated malignant disorders. Lancet. 1998; 351(9119):1833-9. DOI: 10.1016/s0140-6736(97)09028-4. View

Thompson M, Aberg J, Cahn P, Montaner J, Rizzardini G, Telenti A . Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010; 304(3):321-33. DOI: 10.1001/jama.2010.1004. View

Mbulaiteye S, Anderson W, Bhatia K, Rosenberg P, Linet M, Devesa S . Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer. 2009; 126(7):1732-9. PMC: 2818154. DOI: 10.1002/ijc.24934. View

10.

Eltom M, Jemal A, Mbulaiteye S, Devesa S, Biggar R . Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002; 94(16):1204-10. DOI: 10.1093/jnci/94.16.1204. View

11.

Kadan-Lottick N, Skluzacek M, Gurney J . Decreasing incidence rates of primary central nervous system lymphoma. Cancer. 2002; 95(1):193-202. DOI: 10.1002/cncr.10643. View

12.

Rouhani P, Fletcher C, Devesa S, Toro J . Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer. 2008; 113(3):616-27. DOI: 10.1002/cncr.23571. View

13.

Hall H, Song R, Rhodes P, Prejean J, An Q, Lee L . Estimation of HIV incidence in the United States. JAMA. 2008; 300(5):520-9. PMC: 2919237. DOI: 10.1001/jama.300.5.520. View

14.

Engels E, Biggar R, Hall H, Cross H, Crutchfield A, Finch J . Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123(1):187-94. DOI: 10.1002/ijc.23487. View

15.

Frisch M, Biggar R, Engels E, Goedert J . Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001; 285(13):1736-45. DOI: 10.1001/jama.285.13.1736. View

16.

Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R . Classic kaposi sarcoma: epidemiology and risk factors. Cancer. 2000; 88(3):500-17. View

17.

Green T . Using surveillance data to monitor trends in the AIDS epidemic. Stat Med. 1998; 17(2):143-54. DOI: 10.1002/(sici)1097-0258(19980130)17:2<143::aid-sim757>3.0.co;2-y. View

18.

Shiels M, Cole S, Wegner S, Armenian H, Chmiel J, Ganesan A . Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters. J Acquir Immune Defic Syndr. 2008; 48(4):485-90. PMC: 2805176. DOI: 10.1097/QAI.0b013e31817dc42b. View

19.

Sparano J, Lee J, Kaplan L, Levine A, Ramos J, Ambinder R . Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2009; 115(15):3008-16. PMC: 2858478. DOI: 10.1182/blood-2009-08-231613. View

20.

Engels E, Pfeiffer R, Goedert J, Virgo P, McNeel T, Scoppa S . Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006; 20(12):1645-54. DOI: 10.1097/01.aids.0000238411.75324.59. View